Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2019 Oct 22

PMID 31632114

Citations 13

Authors

Elad Shemesh

Barak Zafrir

Affiliations

Soon will be listed here.

Abstract

Disturbances in glucose and lipid homeostasis are cardinal features of the metabolic syndrome that affect millions of people worldwide. These conditions have multi-organ impact, and while cardiovascular effects are usually the core for studies and preventive measures, other systems may also be affected, including the pancreas. Acute pancreatitis related to severe hypertriglyceridemia is an under-recognized condition that could lead to significant morbidity and mortality. Therefore, when suspected, prompt diagnosis and treatment should be initiated to cover the various aspects of this disorder. Though commonly known to be associated with excess of alcohol use, hypertriglyceridemia-related pancreatitis is particularly observed in diabetics, especially when uncontrolled. Here, we portray the possible mechanisms and clinical features that link type 2 diabetes, hypertriglyceridemia and pancreatitis, and discuss their health-related outcomes and the current and novel treatment options for this unique disease.

Citing Articles

Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk.

Berisha H, Hattab R, Comi L, Giglione C, Migliaccio S, Magni P Nutrients. 2025; 17(5).

PMID: 40077646 PMC: 11902110. DOI: 10.3390/nu17050776.

GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges.

Kupnicka P, Krol M, Zychowska J, Lagowski R, Prajwos E, Surowka A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598383 PMC: 11597758. DOI: 10.3390/ph17111470.

Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis.

Fu Z, Zhao Z, Liang Y, Cheng D, Luo J, Jiang H World J Gastroenterol. 2024; 30(35):3996-4010.

PMID: 39351060 PMC: 11438666. DOI: 10.3748/wjg.v30.i35.3996.

The causal relationship between the gut microbiota and acute pancreatitis: A 2-sample Mendelian randomization study.

He L, Luo H, Li Y, Zhang Y, Peng L, Xu Y Medicine (Baltimore). 2024; 103(22):e38331.

PMID: 39259083 PMC: 11142829. DOI: 10.1097/MD.0000000000038331.

A Rare Case of Paxlovid-Induced Pancreatitis.

Zaidi S, Iskander P, Ahmed K, Jaber F, Paz M, Khan A Cureus. 2023; 15(3):e36528.

PMID: 37090326 PMC: 10120881. DOI: 10.7759/cureus.36528.

References

Sue L, Batech M, Yadav D, Pandol S, Blumentals W, von Krusenstiern L . Effect of Serum Triglycerides on Clinical Outcomes in Acute Pancreatitis: Findings From a Regional Integrated Health Care System. Pancreas. 2017; 46(7):874-879. PMC: 6908305. DOI: 10.1097/MPA.0000000000000860. View

Krishna S, Kamboj A, Hart P, Hinton A, Conwell D . The Changing Epidemiology of Acute Pancreatitis Hospitalizations: A Decade of Trends and the Impact of Chronic Pancreatitis. Pancreas. 2017; 46(4):482-488. PMC: 5435121. DOI: 10.1097/MPA.0000000000000783. View

Xie S, Chen T, Huang X, Chen C, Jin R, Huang Z . Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis. PLoS One. 2015; 10(6):e0129488. PMC: 4469420. DOI: 10.1371/journal.pone.0129488. View

Berglund L, Brunzell J, Goldberg A, Goldberg I, Sacks F, Murad M . Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(9):2969-89. PMC: 3431581. DOI: 10.1210/jc.2011-3213. View

Christophersen B, Nordstoga K, Shen Y, Olivecrona T, Olivecrona G . Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology. J Lipid Res. 1997; 38(5):837-46. View

Stroes E, Susekov A, de Bruin T, Kvarnstrom M, Yang H, Davidson M . Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. J Clin Lipidol. 2018; 12(2):321-330. DOI: 10.1016/j.jacl.2017.10.012. View

Retterstol K, Narverud I, Selmer R, Berge K, Osnes I, Ulven S . Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics. Lipids Health Dis. 2017; 16(1):115. PMC: 5469061. DOI: 10.1186/s12944-017-0511-9. View

Zafrir B, Jubran A, Hijazi R, Shapira C . Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service. J Clin Lipidol. 2018; 12(4):928-936. DOI: 10.1016/j.jacl.2018.03.086. View

Landray M, Haynes R, Hopewell J, Parish S, Aung T, Tomson J . Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014; 371(3):203-12. DOI: 10.1056/NEJMoa1300955. View

10.

Nordstoga K, Christophersen B, Ytrehus B, Espenes A, Osmundsen H, Landsverk T . Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells. J Comp Pathol. 2006; 134(4):320-8. DOI: 10.1016/j.jcpa.2006.01.003. View

11.

Rubins H, Robins S, Collins D, Nelson D, Elam M, Schaefer E . Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med. 2002; 162(22):2597-604. DOI: 10.1001/archinte.162.22.2597. View

12.

Zhang R, Deng L, Jin T, Zhu P, Shi N, Jiang K . Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity. HPB (Oxford). 2019; 21(9):1240-1249. DOI: 10.1016/j.hpb.2019.01.015. View

13.

Eckerwall G, Tingstedt B, Bergenzaun P, Andersson R . Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery--a randomized clinical study. Clin Nutr. 2007; 26(6):758-63. DOI: 10.1016/j.clnu.2007.04.007. View

14.

Lai S, Muo C, Liao K, Sung F, Chen P . Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol. 2011; 106(9):1697-704. DOI: 10.1038/ajg.2011.155. View

15.

Ansquer J, Bekaert I, Guy M, Hanefeld M, Simon A . Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm,.... Am J Cardiovasc Drugs. 2009; 9(2):91-101. DOI: 10.1007/BF03256580. View

16.

Harris W, Bulchandani D . Why do omega-3 fatty acids lower serum triglycerides?. Curr Opin Lipidol. 2006; 17(4):387-93. DOI: 10.1097/01.mol.0000236363.63840.16. View

17.

Oikawa S, Yamashita S, Nakaya N, Sasaki J, Kono S . Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study. J Atheroscler Thromb. 2016; 24(1):77-94. PMC: 5225135. DOI: 10.5551/jat.35626. View

18.

Villatoro E, Mulla M, Larvin M . Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010; (5):CD002941. PMC: 7138080. DOI: 10.1002/14651858.CD002941.pub3. View

19.

Guda N, Muddana V, Whitcomb D, Levy P, Garg P, Cote G . Recurrent Acute Pancreatitis: International State-of-the-Science Conference With Recommendations. Pancreas. 2018; 47(6):653-666. DOI: 10.1097/MPA.0000000000001053. View

20.

Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls S . Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010; 375(9729):1875-84. DOI: 10.1016/S0140-6736(10)60656-3. View